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Abstract The dominantly inherited cerebellar ataxias are
a heterogeneous group of neurodegenerative disorders
caused by Purkinje cell loss in the cerebellum. Recently,
we identified loss-of-function mutations in the KCND3
gene as the cause of spinocerebellar ataxia type 19/22
(SCA19/22), revealing a previously unknown role for the
voltage-gated potassium channel, Kv4.3, in Purkinje cell
survival. However, how mutant Kv4.3 affects wild-type
Kv4.3 channel functioning remains unknown. We provide
evidence that SCA19/22-mutant Kv4.3 exerts a dominant
negative effect on the trafficking and surface expression of
wild-type Kv4.3 in the absence of its regulatory subunit,
KChIP2. Notably, this dominant negative effect can be
rescued by the presence of KChIP2. We also found that all
SCA19/22-mutant subunits either suppress wild-type
Kv4.3 current amplitude or alter channel gating in a
dominant manner. Our findings suggest that altered Kv4.3
channel localization and/or functioning resulting from
SCA19/22 mutations may lead to Purkinje cell loss, neu-
rodegeneration and ataxia.
Keywords KCND3  Kv4.3  Spinocerebellar ataxia 
Purkinje cells  Voltage-gated potassium channel
Introduction
Spinocerebellar ataxia type 19/22 (SCA19/22) is a
dominantly inherited neurodegenerative, clinically hetero-
geneous disorder caused by mutations in KCND3, which
encodes the voltage-gated potassium channel Kv4.3 [1–3].
Currently, all the SCA19/22 mutations that have been re-
ported lead to a loss of Kv4.3 current amplitude in studies
focused on single mutant Kv4.3 subunits [1, 3]. Functional
Kv4.3 subunits are assembled as tetrameric complexes and
controlled by a large variety of regulatory auxiliary pro-
teins, including KChIPs (potassium channel interacting
proteins), which interact with the tetrameric channels to
form octomeric complexes, thereby regulating the expres-
sion and subcellular localization of the functional subunits
(Kv4) and modifying their intrinsic properties [4–6]. Kv4.3
channels exhibit fast activation and inactivation in response
to membrane depolarization and recover faster from inac-
tivation than other voltage-gated potassium channels, thus
playing an important role in the generation of neuronal
transient A-type potassium currents in brain (IA) [7–12],
heart and smooth muscle [7, 13–15]. Neuronal IA currents
control the spike frequency and the back-propagation of
action potentials, processes which are particularly impor-
tant for Purkinje cell firing [16]. Alterations in Purkinje cell
firing could be an early disease manifestation of SCA19/22,
as has been observed in other spinocerebellar ataxias
(SCA2, SCA3 and SCA27) [17–20]. These alterations may
Electronic supplementary material The online version of this
article (doi:10.1007/s00018-015-1894-2) contains supplementary
material, which is available to authorized users.
& Dineke S. Verbeek
d.s.verbeek@umcg.nl
1 Department of Genetics, University of Groningen, University
Medical Center Groningen, PO Box 30 001, 9700 RB
Groningen, The Netherlands
2 Department of Medical Physiology, University of Groningen,
University Medical Center Groningen, 9700 RB Groningen,
The Netherlands
3 Department of Cell Biology, University of Groningen,
University Medical Center Groningen, 9700 RB Groningen,
The Netherlands
4 Department of Physiology, University of California at Los
Angeles, Los Angeles, CA 90095-1751, USA
Cell. Mol. Life Sci. (2015) 72:3387–3399
DOI 10.1007/s00018-015-1894-2 Cellular and Molecular Life Sciences
123
lead to the severe degeneration of Purkinje cells that was
found in the atrophic cerebellar vermis of an SCA19 pa-
tient [3, 21].
The question remains whether the SCA19/22 mutations
result in reduced Kv4.3 channel activity due to haploin-
sufficiency through pure loss of function and/or due to the
mutant proteins acting as dominant negative suppressors of
the wild-type Kv4.3 subunits. The latter has been proven
for mutations in Kv1.1, which cause episodic ataxia type 1
(EA1) and which display dominant negative effects on
potassium currents associated with different clinical phe-
notypes in EA1 patients [22–26]. Similarly, mutations in
Kv3.3 that underlie spinocerebellar ataxia type 13 (SCA13)
also seem to result in a loss of function or altered channel
gating properties in a dominant manner [27–29]. In this
case, depending on the effect of the mutation on Kv3.3
functioning, SCA13 patients exhibit early onset (channel
gating deficits) or late onset (loss of channel activity) of the
disease. It has also been shown that expression of SCA13
mutant Kv3.3 in Purkinje cells induce cell death by altered
excitability or elevated intracellular calcium [30]. More-
over, alterations in the intracellular potassium homeostasis
caused by modified Kv signaling can also cause neuronal
death [31, 32]. Together, these data imply that Kv channels
play an important role in maintaining (cerebellar) neuronal
viability.
For SCA19/22, as a dominant disease, we aimed to
elucidate whether its pathology is caused by haploinsuffi-
ciency through pure loss of Kv4.3 function and/or whether
the mutant proteins act as dominant negative suppressors of
the wild-type Kv4.3 subunits. We therefore studied wild-
type (WT) Kv4.3 trafficking and channel complex forma-
tion and function in the presence of SCA19/22-mutant
Kv4.3 subunits, to advance our understanding of the un-
derlying disease mechanism(s). All SCA19/22-mutant
Kv4.3 subunits exerted dominant negative effects on WT
Kv4.3 trafficking leading to intracellular retention and
enhanced protein instability of the WT/mutant Kv4.3
channel heterocomplexes that could be rescued by KChIP2.
Notably, the trafficking deficit was caused by temperature-
sensitive misfolding of the mutant subunits. Only the
T352P mutation dominantly reduced the channel activity of
WT/T352P heterocomplexes in a dose-dependent manner
in Xenopus oocytes. In contrast, the DF227, M373I and
S390N mutations altered the gating kinetics of the WT/
DF227, WT/M373I and WT/S390N heterocomplexes in a
dominant and different manner. Our work demonstrates
how difficult it is to establish a common underlying
pathological mechanism for SCA19/22, a problem that is
reflected in the clinical heterogeneity of this disease. Fur-
ther work is necessary to reveal the detailed contribution of
the mutant Kv4.3 channel subunit in the native IA current




The pcDNA3.1-Kv4.3 WT and mutant plasmids was gen-
erated as previously described [3], and to generate the
DF227 mutant, side-directed mutagenesis was performed
using the primers forward 50-GGTGGCCTTCTGCCTGGA
CACG-30 and reverse 50-CGTGTCCAGGCAGAAGGCC
ACC-30. To generate Kv4.3 fused to enhanced green
fluorescent protein (EGFP), wild-type (WT) and mutant
Kv4.3 cDNAs were subcloned into pEGFP-N1 (Clontech)
using the XhoI and EcoRI restriction sites. An extracellular
hemagglutinin tag (HA: YPYDVPDYA) was introduced
into the cDNA of pcDNA3.1-Kv4.3 wild type (WT) and
mutants (T352P, M373I, S390N and DF227) in the extra-
cellular loop between transmembrane domains S1 and S2
(L216-P217) using site-directed mutagenesis via forward
primer 50-CCGGGCAGCAAGGAGCTGTACCCATACGA
CGTCCCAGACTACGCTCCGTGCGGGGAGCGTAC-30
and reverse primer 50-GTACGCTCCCCGCACGGAGCGT
AGTCTGGGACGTCGTATGGGTACAGCTCCTTGCTG
CCCGG-30, as described previously for Kv4.2. All con-
structs were verified by Sanger sequencing. The addition of
HA and EGFP tags to Kv4.3 did not affect the functional
properties of the channel (Fig. S1). The Emerald-KChIP2b
was provided by Dr. K. Takimoto (Nagaoka University
of Technology, Kamitomoika, Japan) and the cDNA of
KChIP2b (referred to as KChIP2) was subcloned in
pcDNA3.1 via NcoI.
Cell culture, transfection and cycloheximide
treatment
HeLa cells were grown in Dulbecco’s Modified Eagle’s
Medium (Invitrogen) supplemented with 10 % fetal bovine
serum (Invitrogen) and 1 % penicillin–streptomycin (Gib-
co) in a 37 C incubator with 5 % CO2. Transfections were
done using polyethylenimine (Polysciences), according to
the manufacturer’s instructions. To generate WT/mutant
heterocomplex Kv4.3 channels or to generate WT or mu-
tant homocomplex Kv4.3–KChIP2 channels, all plasmids
were expressed in 1:1 ratio. Additionally, to generate
WT/mutant heterocomplex Kv4.3–KChIP2 channels,
plasmids containing WT, mutant Kv4.3 and KChIP2 were
transfected in 0.5:0.5:1 ratio. For example, the amount of
DNA used for the protein stability experiments was 0.5 lg
WT Kv4.3, 0.5 lg mutant Kv4.3 and 1 lg KChIP2 (6 well
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plate). For the immunocytochemistry and FACS ex-
periments, the amount of plasmid DNA transfected was
0.25 lg WT Kv4.3, 0.25 lg mutant Kv4.3 and 0.5 lg
KChIP2 (24 well plate). The protein stability was assessed
treating the HeLa cells with a protein synthesis inhibitor
cycloheximide (CHX; 25 lg/ml; Sigma) for 0, 3 and 6 h,
and protein expression was analyzed by Western blot and
quantified as described previously [3].
Immunological methods
Immunocytochemistry was performed as previously de-
scribed with some modifications [3]. Briefly, for the
complex formation HA–Kv4.3 WT and EGFP-fused Kv4.3
WT or mutants were expressed in HeLa cells (which do
not express any Kv regulatory subunit) in the presence
or absence of KChIP2. Cells were fixed in 4 %
paraformaldehyde in saline phosphate buffer (PBS) for
15 min., permeabilized and blocked in PB buffer (0.1 %
Triton X-100, 5 % normal goat serum (NGS) in PBS) for
30 min at room temperature, followed by incubation with
the primary antibodies anti-HA (3F10) (1:250; Roche) and
anti-KChIP2 (1:250; Abcam) in PBS buffer at 4 C over-
night. Then, cells were washed and incubated with the
secondary antibodies goat Alexa 647-conjugated anti-rat
and Cy3-conjugated anti-mouse (1:500; Jackson Lab) in
PB buffer for 1 h and mounted using Vectashield mounting
medium (Vector Labs). For the cell surface detection at
30 C vs. 37 C, HeLa cells were transfected with HA-
tagged WT or mutant Kv4.3 and cells were cultured at
30 C or 37 C for 24 h. Cells were fixed in 4 %
paraformaldehyde in PBS for 15 min and blocked with 5 %
NGS in PBS for 30 min. Non-permeabilized cells were
incubated with anti-HA (3F10) (1:250; Roche) overnight at
4 C, to detect only the protein at the plasma membrane
and goat Alexa 647-conjugated anti-rat. Stacks were ac-
quired using a Leica DMI 6000 Inverted microscope
(Leica) equipped with a 409 and 639 oil immersion lens.
Images were processed using ImageJ software (National
Institutes of Health, Bethesda, MA, USA). The subcellular
localization of the WT/mutant heterocomplex Kv4.3
channels with and without KChIP2 is also depicted as cell
fluorescence intensity plot profiles (Fig. S2). These figures
combine the outcomes of the immunofluorescence ex-
periments as shown in Figs. 1 and 3. In addition, the
addition of cycloheximide to cells transfected with the
various heterocomplex channels did not change the cellular
localization of the channel complexes (Fig. S3).
For the cell surface quantification using flow cytometry
of the WT/mutant heterocomplex Kv4.3 channels, HeLa
cells were transfected with a combination of extracellular
HA-tagged WT with EGFP-tagged Kv4.3 WT or mutants,
and HA-tagged mutant with EGFP-tagged Kv4.3 WT,
either with or without KChIP2. For quantification of cell
surface expression of WT or mutant Kv4.3 subunits at 30
vs. 37 C, HeLa cells were transfected with HA–WT or
HA–mutant Kv4.3 together with GFP (used to quantify the
total amount of transfected cells) and cultured at 30 or
37 C for 24 h. Cells expressing WT Kv4.3 together with
WT-Kv4.3-HA were used as positive control and non-
transfected cells were used as a negative control. Non-
permeabilized cells were incubated with anti-HA (3F10)
antibody (1:500, Roche) for 2 h at 37 C or at 30 C and
secondary Alexa647-conjugated anti-rat antibody (1:500,
Jackson Lab). After washing, cells were re-suspended in
500 ll ice-cold 10 % fetal bovine serum in PBS. Cyto-
metric analysis was performed using an FACS Calibur flow
cytometer (BD Biosciences) with 488 and 635 nm lasers,
and analyzed using the Cell Quest Pro software (BD Bio-
sciences). Representative images for the FACS analysis are
shown in Fig. S4.
For protein analysis, cells were homogenized in 2 %
SDS-PBS buffer containing protease inhibitor cocktail
(Roche) and protein concentration was determined using
the BCA method (BioRad). Then, 50 lg of protein were
separated in an SDS-PAGE, blotted in nitrocellulose
membrane, blocked and incubated with mouse anti-Kv4.3
(K75/41; NeuroMab; 1:1000), mouse anti-actin (MP Bio-
chemicals; 1:5000) and mouse anti-KChIP2 (Abcam;
1:1000). Final quantification was performed using the
program Quantity One (Bio-Rad).
Electrophysiology in oocytes
The Xenopus laevis oocyte expression system was used to
characterize the functional properties of WT and mutant
Kv4.3 channels in the presence of KChIP2. All animal
procedures were approved by the Chancellor’s Animal
Research Committee at the University of California, Los
Angeles. RNA was transcribed in vitro using the mMes-
sage mMachine T7 Ultra kit (Ambion) and injected into
stage V–VI oocytes. RNAs (160–200 ng) encoding WT or
mutant Kv4.3 or a mixture of WT and mutant Kv4.3 were
co-injected with RNA encoding KChIP2, which was in-
cluded at equimolar amounts to WT Kv4.3. The oocytes
were kept in an 18 C incubator and all oocyte recordings
were performed at room temperature (*18 C). Potassium
currents were recorded 1–3 days later using a Warner
OC-725 two-electrode voltage clamp, as described previ-
ously with some modifications [27, 33, 34]. Electrodes
were filled with 3 M KCl and had resistances ranging from
0.3 to 1.0 MX. The bath solution contained 2 mM KCl,
96 mM NaCl, 0.5 mM CaCl2 and 5 mM HEPES, pH 7.5.
Alternatively, in some experiments the bath solution con-
tained 2 mM KCl, 96 mM NaCl, 1.8 mM CaCl2, 1 mM
MgCl2 and 5 mM HEPES, pH 7.5 (Fig. S5). Linear leak
Spinocerebellar ataxia type 19/22 mutations alter… 3389
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and capacitive currents were subtracted using a P/-4 pro-
tocol. The conductance/voltage relationship was
determined by pulsing the membrane from a holding po-
tential of -100 mV to voltages ranging from -80 to
?70 mV in 10 mV increments. Conductance values were
calculated from peak current amplitudes assuming a linear
open channel current–voltage relationship and a reversal
potential of -95 mV, and normalized to the maximum
value obtained in the experiment. Normalized conductance
values were plotted versus voltage and fitted with a single
Boltzmann function to obtain values for V,act and the
slope factor. Mean current density plots were generated by
measuring the peak current amplitudes as a function of
voltage and normalized to that for wild-type Kv4.3
expressed in parallel in the same batch of oocytes. Data
from different batches of oocytes were then averaged. RNA
encoding KChIP2 was co-injected at an equimolar ratio
with the total amount of Kv4.3 RNA.
To characterize the steady-state properties of inactiva-
tion, the voltage was stepped from the holding potential
(-100 mV) to prepulse potentials ranging from -130 to
?10 mV for 1 s to allow inactivation to occur. The
membrane was then stepped to the test potential of
?60 mV for 1 s. The extent of inactivation during the
prepulse was calculated as the ratio of peak current am-
plitude during the test pulse relative to the peak current
amplitude at ?60 mV in the absence of a prepulse (I/Imax).
Data were plotted as a function of prepulse voltage and
Fig. 1 WT/mutant Kv4.3 heterocomplexes are intracellulary retained
and less stable than WT/WT Kv4.3 homocomplexes. a The confocal
images show the anti-HA immuno-staining of permeabilized and
fixed HeLa cells co-expressing HA–Kv4.3 WT (blue) and EGFP-
fused WT, -T352P, -M373I, -S390N or -DF227 Kv4.3 (green). Scale
bar 20 lm. b Flow cytometry was used to quantify the extracellular
HA-tagged Kv4.3 WT (black bars) or mutant Kv4.3 (gray bars) at the
plasma membrane of non-permeabilized HeLa cells expressing either
WT/WT homocomplexes or WT/mutant heterocomplexes. The cells
expressing Kv4.3 WT on the plasma membrane in the presence of any
of the mutant subunits were strongly reduced compared with that in
the presence of another WT subunit (black bars; WT/WT 79 % vs.
WT/T352P: 21 %, WT/M373I: 55 %, WT/S390N: 49 % and WT/
DF227: 20 %). Likewise, markedly reduced levels of all HA-tagged
Kv4.3 mutant subunits were observed in the presence of WT (gray
bars; WT/WT 84 % vs. T352P/WT: 16 %, M373I/WT: 41 %,
S390N/WT: 17 % and DF227/WT: 24 %). c After 6 h of cyclohex-
imide (CHX) treatment, the WT/mutant heterocomplexes were more
rapidly degraded than the WT/WT homocomplexes (remaining
protein WT/WT: 34 ± 1.1 %; WT/T352P: 16.1 ± 4.4 %; WT/
M373I: 14.7 ± 1.9 %; WT/S390N: 29.7 ± 0.6 %, but not for WT/
DF227: 32.5 ± 7.4 %). The bars represent the normalized expression
of WT EGFP-Kv4.3 at t = 0 shown in percentages. Data in b and
c represent the average of three independent experiments and the
error bars represent the mean ± SEM, t test and ANOVA *p\ 0.05
vs. WT in b and p\ 0.005 vs. WT in c
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fitted with a Boltzmann function to determine the midpoint
voltage, V,inact and the slope factor. The kinetics of re-
covery from inactivation at -80 mV were assessed using a
two-pulse protocol, in which two pulses to ?60 mV were
applied separated by an interpulse interval of varying du-
ration at -80 mV. The fractional recovery was calculated
as the ratio of the peak current amplitude during the second
pulse to that of the first pulse (I/Imax). This ratio was plotted
versus the interpulse duration. The time to reach peak
amplitude was measured by evoking currents at ?60 mV,
which were then scaled to the same amplitude and overlaid.
Additionally, the fraction of current remaining at the end of
the pulse was measured. Data were fitted with one expo-
nential component to estimate the recovery time constant,
srec.
Statistical analysis
The data obtained from the flow cytometry and Western
blot densitometries were analyzed by one-way analysis of
variance (ANOVA) followed by Student’s t test. All data
shown are representative for at least three independent
experiments and presented as mean ± SEM. The electro-
physiology experiments were analyzed with ANOVA
followed by Student’s t test. P values less than 0.05 were
considered significant.
Results
Kv4.3 mutants display a dominant negative effect
on the trafficking and stability of the wild-type
protein
We and others have previously shown that the T352P,
M373I, S390N and DF227 mutant homocomplexes ex-
hibit impaired trafficking and/or stability [1, 3]. Since
SCA19/22 patients carry one WT and one mutant KCND3
allele, we wondered whether the mutant (T352P, M373I,
S390N and DF227) and WT Kv4.3 subunits would
assemble into functional tetrameric WT/mutant hetero-
complexes at the plasma membrane. We first studied the
effect of the mutant subunits on the protein trafficking of
WT Kv4.3. To study the subcellular localization of the
WT/mutant heterocomplexes, HA-tagged WT Kv4.3 was
co-expressed with either enhanced green fluorescent
protein (EFGP)-fused T352P, M373I, S390N, DF227 or
WT Kv4.3 in HeLa cells. Immunocytochemistry revealed
that, in the presence of any mutant subunit, WT Kv4.3
was mainly detected intracellularly co-localizing with
the mutant subunit, and almost no plasma membrane
localization was seen (Fig. 1a). In contrast, WT/WT
homocomplexes showed abundant plasma membrane lo-
calization. Flow cytometric analysis was used to quantify
the presence of the extracellular HA-tagged WT or mutant
Kv4.3 at the plasma membrane of non-permeabilized
cells. These results confirmed the strongly reduced WT
Kv4.3 signal at the plasma membrane in the presence of
any mutant subunit (Fig. 1b, black bars), coinciding with
similarly low levels of mutant Kv4.3 at the cell surface in
the presence of WT (Fig. 1b, gray bars).
Since the ER-retained mutant proteins were previously
shown to be unstable [3], we next assessed the protein
stability of WT Kv4.3 in the presence of the mutant sub-
units. A time course cycloheximide (CHX) experiment was
performed in HeLa cells expressing WT EGFP-Kv4.3 to-
gether with either WT or mutant subunits. The fraction of
protein remaining was analyzed by Western blot and
quantified, revealing that despite similar initial protein
levels, after 6 h of CHX treatment, WT Kv4.3 degraded
significantly faster in the presence of T352P, M373I and
S390N mutants than in the presence of DF227 or another
WT subunit (Fig. 1c). The change in the cellular local-
ization of the WT/mutant heterocomplex Kv4.3 channels
was not due to the reduced protein stability of these com-
plexes (Fig. S3). These data clearly indicate that all mutant
subunits have a dominantly negative effect on the traf-
ficking of WT Kv4.3 to the plasma membrane, resulting in
intracellular retention of WT/mutant heterocomplexes.
Furthermore, the data show that T352P, M373I and S390N
(but not DF227) cause reduced protein stability of the
heterocomplexes in a dominant manner.
SCA19/22-mutant Kv4.3 subunits exhibit
a temperature-sensitive folding deficit
Additionally, we tested if the trafficking defect observed
for the SCA19/22 mutants was temperature sensitive as this
has been seen before for other mutant channels, including
DF508 mutant cAMP-regulated chloride channels (CFTR)
[35–37] or N470D mutant Kv11.1 channels [38, 39]. To
improve the protein trafficking of mutant Kv4.3 to the
plasma membrane, HeLa cells expressing either WT Kv4.3
or T352P, M373I, S390N and DF227 mutant Kv4.3 con-
taining an extracellular HA-tag were incubated at 30 C
followed by immunofluorescence analysis. Notably, cul-
turing at 30 C led to markedly increased levels of all the
mutant Kv4.3 homocomplex channels at the plasma
membrane (Fig. 2a, right panel), whereas cells cultured at
37 C had significantly lower levels at the plasma mem-
brane compared with WT Kv4.3 (Fig. 2a, left panels). We
pursued this temperature effect further using flow cy-
tometry to quantify the percentage of cells expressing
Kv4.3 channel complexes at the plasma membrane and
Spinocerebellar ataxia type 19/22 mutations alter… 3391
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confirmed that cell surface expression of all the mutant
channel complexes was significantly increased at 30 C
compared to 37 C (Fig. 2b). Given that low-temperature
culturing restored proper plasma membrane localization of
all mutant channel complexes, our findings indicate that
SCA19/22 mutations in Kv4.3 induce a temperature-sen-
sitive folding/trafficking defect.
KChIP2 drives stable and correctly assembled
WT/mutant heterocomplex Kv4.3 channels
at the plasma membrane
We have previously shown that KChIP2 was able to rescue
the trafficking defects and protein instability of the single
T352P and M373I subunits. However, KChIP2 was unable
to rescue these deficits for S390N [3] and DF227 channels
(unpublished data). We therefore wondered whether
KChIP2 could also rescue the intracellularly trapped
WT/mutant heterocomplexes. To examine whether this is
the case, we expressed KChIP2 with HA–WT Kv4.3 and
EGFP-mutant subunits in a 1:1 ratio in HeLa cells. KChIP2
was able to rescue the trafficking deficits of all WT/mutant
heterocomplexes, including the complexes containing
S390N or DF227 subunits, as shown by immunocyto-
chemistry (Fig. 3a; Fig. S2). Flow cytometry analysis
confirmed the presence of both HA–WT and HA–mutant
Kv4.3 subunits in similar levels at the cell surface in the
presence of KChIP2 (Fig. 3b), indicative of a properly
assembled Kv4.3 WT/mutant heterocomplex. Additionally,
the protein stability of the WT/mutant heterocomplexes was
assessed using a time course CHX experiment in HeLa cells
in the presence or absence of KChIP2. Our data show that
KChIP2 also prevented the rapid degradation of the
WT/mutant heterocomplexes (Fig. 3c), restoring the protein
stability to the same levels of WT/WT homocomplexes.
These data show that KChIP2 can eliminate the domi-
nant negative effect of the mutant subunits on the
trafficking and stability of the WT/mutant heterocom-
plexes. Thus, in the presence of sustainable levels of
KChIP2, stable and correctly assembled WT/mutant hete-
rocomplex Kv4.3 channels are located at the plasma
membrane in a heterologous system.
Fig. 2 Kv4.3 mutant subunits exhibit a temperature-sensitive folding
defect. a Images of HeLa cells expressing HA–Kv4.3 WT or HA–
T352P, –M373I, –S390N and –DF227 incubated at 37 C or at 30 C
for 24 h. Non-permeabilized cells were stained using anti-HA
antibody to detect Kv4.3 at the plasma membrane. Scale bar
20 lm. b Flow cytometry analysis is used to quantify the level of
HA–Kv4.3 at the cell surface in HeLa cells cultured at 37 C or at
30 C. The graphs show a significant increase in the number of cells
expressing the mutant subunits at the plasma membrane cultured at
30 C (black bars; WT: 89 % ± 1.8; T352P: 86.9 % ± 1.2; M373I:
89.5 % ± 1.4; S390N: 77.8 % ± 3.3; and DF227: 67.8 % ± 10.1)
compared to cells cultured at 37 C (gray bars; WT: 96.5 % ± 2.1;
T352P: 55.4 % ± 5.5; M373I: 71.1 % ± 3.4; S390N: 33.4 % ± 3;
and DF227: 13.1 % ± 0.6). Bars show the average of three indepen-
dent experiments (mean ± SEM, *p\ 0.01, **p\ 0.001)
3392 A. Duarri et al.
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T352P mutant Kv4.3 suppresses WT Kv4.3 activity
in Xenopus oocytes, while M373I, S390N and DF227
mutant subunits alter channel properties
in a dominant manner
Since correctly assembled macromolecular heterocom-
plexes consisting of KChIP2, WT and mutant Kv4.3
subunits are present at the plasma membrane, we wondered
whether these channel complexes were functionally active.
The Xenopus oocyte expression system was used to analyze
the strength of any dominant effects of the mutant Kv4.3
subunits and to determine the effects of the mutations on
the functional properties of WT/mutant heterocomplexes.
Advantageously, oocytes are kept at 18 C, which could
enhance the rescue of temperature-dependent folding and
trafficking defects in a manner similar to that observed for
HeLa cells at 30 C.
For functional analysis in oocytes, RNA encoding WT
Kv4.3, mutants or an equal mixture of WT and mutant was
co-injected with KChIP2 RNA (1:1). Electrophysiological
experiments were performed at *18 C. Representative
current traces, 150 ms in duration, are shown in Fig. 4a–f.
Compared with WT Kv4.3 (Fig. 4a), M373I and S390N
homocomplexes resulted in robust K? currents (Fig. 4b, c)
and the DF227 subunit produced active channels, but with
significantly reduced current amplitudes (Fig. 4d). Current
amplitudes were increased when the DF227 subunit was
coexpressed at a 1:1 ratio with WT subunits (Fig. 4e). In
contrast, no channel activity was detected for T352P ho-
mocomplexes (Fig. 4f). To determine if there was any
dominant negative effect of the mutant subunit, T352P was
co-expressed with WT at various ratios. This led to a
marked dose-dependent suppression of current amplitude
compared with the current amplitude of WT homocom-
plexes (Fig. 4g, h). In contrast, WT/M373I and WT/S390N
heterocomplexes produced active channels (Table 1). To
further characterize the effects of the mutations on current
amplitude, mean current density plots were generated for
WT, DF227, WT/DF227 and WT/T352P channel com-
plexes (Fig. 4i). Normalized peak current amplitudes were
significantly reduced for WT/T352P heterocomplexes and
DF227 homocomplexes. Thus, T352P exerts marked
dominant suppression of WT channel activity. DF227
forms active channels less efficiently than WT, but peak
current amplitude was restored to the WT level when
DF227 was co-expressed with WT subunits. M373I and
S390N form fully active homocomplexes and WT/mutant
heterocomplexes.
In all cases, K? currents showed rapid activation and
subsequent inactivation characteristic of Kv4.3 channels.
In our experiments, inactivation was slower than in pre-
vious reports, because currents were recorded at *18 C
rather than the more typical 22 C (Fig. S4). At the lower
temperature, a slow component of inactivation dominates
the kinetics of current decay, whereas at 22 C fast and
slow components make similar contributions to decay
kinetics (Table S1). We compared the steady-state prop-
erties of activation in WT and mutant homo- and
heterotetrameric channels by determining peak conduc-
tance/voltage relationships (Fig. 5a). The data sets were
fitted with single Boltzmann equations to obtain values for
the voltage at which 50 % of the channels are activated
(V,act) and the slope factor (Table 1). The DF227 homo-
complexes significantly shifted the value of V,act by
?27 mV in the depolarized direction and the activation of
WT/DF227 (1:1) heterocomplexes was shifted by ?9 mV
(Fig. 5a; Table 1), a value intermediate to WT and DF227
alone. In contrast, the other mutant homo- and hetero-
complexes had V,act values similar to those of WT.
Additionally, M373I homocomplexes and WT/M373I (1:1)
heterocomplexes had significantly reduced slope factors
compared to WT (Table 1), and S390N had small but
statistically significant effects on the slope factor of the
activation curve, increasing the value by 2 mV, indicative
of a partial dominant effect on the steady-state activation.
To quantitatively compare the kinetic properties of ac-
tivation and inactivation in mutant and WT channels, we
measured the time to reach peak current amplitude and the
ratio of current amplitude measured at the end of a 150 ms
pulse to ?60 mV relative to the peak current amplitude
(I150ms/Ipeak) (Fig. 5b–d; Table 1). The time to reach peak
current amplitude reflects the competing processes of ac-
tivation and inactivation. Therefore, changes in the time to
peak may reflect changes in the rate of activation, inacti-
vation or some combination of the two. Both DF227 and
M373I homocomplexes significantly increased the time to
peak compared to WT homocomplexes, whereas S390N
channels reached the peak amplitude faster (Fig. 5b, c;
Table 1). In contrast, the time to peak in WT/DF227 and
WT/S390N (1:1) heterocomplexes did not differ sig-
nificantly from WT expressed alone, while in WT/T352P
channels the time to peak was significantly decreased
(Fig. 5b, c; Table 1). The I150ms/Ipeak ratio was significantly
decreased in DF227, S390N homocomplexes and WT/
T352P (1:1) heterocomplexes compared to WT alone,
consistent with the idea that these mutations increase the
rate of inactivation (Fig. 5d; Table 1). In contrast, the
I150ms/Ipeak ratio was unchanged in M373I homocomplexes
and WT/DF227 (1:1) heterocomplexes (Fig. 5d; Table 1).
The effects of the mutations on the voltage dependence
and extent of inactivation were analyzed using a two-pulse
protocol. The data sets were plotted as a function of pre-
pulse voltage and fitted with Boltzmann functions to
determine the midpoint voltage, V,inact, at which 50 % of
the channels are inactivated and the slope factor (Fig. 5e;
Table 1). For the DF227 and M373I homocomplexes,
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V,inact shifted toward the depolarized direction. In con-
trast, for S390N homocomplexes, V,inact shifted in the
hyperpolarized direction. Notably, WT/DF227 (1:1) hete-
rocomplexes did not show changes in the voltage
dependence of inactivation and behaved like WT homo-
complexes, whereas WT/M373I and WT/S390N (1:1)
heterocomplexes exhibited the same shift in inactivating
voltage as the respective mutant homocomplex channels.
Alterations in the slope factor were only detected for
DF227 and S390N homocomplexes (Table 1). These data
indicate that only the M373I and S390N mutations exhibit
dominant effects on steady-state inactivation, whereas
T352P and DF227 do not.
Lastly, we assessed the kinetics of recovery from inac-
tivation, by calculating the ratio of the peak amplitude of
two separate pulses (I/Imax), and the I/Imax was plotted
versus the interpulse duration (Fig. 5f). Note that the
curves in Fig. 5f are offset from each other due to
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differences in the extent of inactivation during the first
pulse. Data were fitted with one exponential component to
estimate the recovery time constant, srec (Table 1). Nota-
bly, only DF227 homocomplexes significantly decreased
srec, indicating that the DF227 mutation increased the rate
of recovery from inactivation (Fig. 5f; Table 1). But,
again, WT/DF227 heterocomplexes (ratio 1:1) behaved like
WT homocomplexes, indicating the absence of a dominant
effect for this end point as well. In contrast, none of the
other mutations affected the rate of recovery from
inactivation.
Discussion
We have clearly shown that all SCA19/22-mutant Kv4.3
subunits exhibit dominant effects on WT protein function
and revealed that both haploinsufficiency by loss of func-
tion and dominant (negative) effects may contribute to the
disease etiology. We consider three potential scenarios
leading to partial haploinsufficiency and/or dominant
(negative) effects due to SCA19/22 mutations. In inter-
preting our data, we assume that the formation of
WT/mutant heterocomplexes is a stochastic process in
which WT and mutant subunits assemble randomly in te-
trameric complexes when they are expressed in a 1:1 ratio.
Additionally, we assume that the stoichiometry of Kv4.3/
KChIP2 complex is variable and depends on the expression
levels of KChIP2. This was supported by a recent publi-
cation that showed that the stoichiometry of Kv4.2/KChIP4
complex depends on the expression level of KChIP4 [40].
In all our experiments, we expressed Kv4.3/KChIP2 at
equal levels.
In our first scenario, the assembly of S390N and DF227
mutant homocomplexes, even in the presence of KChIP2,
causes partial haploinsufficiency due to almost complete
endoplasmic reticulum retention and reduced channel
complex stability. Dominant negative effects on the plasma
membrane trafficking have also been seen in other potas-
sium channelopathies, such as long QT syndrome type 1
and 2, nonsyndromic sensorineural deafness type 2 and
SCA13, which are disorders caused by truncating and
missense mutations in other voltage-gated potassium
channels Kv7.1, Kv11.1, Kv7.4 and Kv3.3, respectively
[41–44]. The dominant effect on WT protein trafficking
exerted by these mutant Kv channels might be due to the
existence of a common pathomechanism underlying dif-
ferent Kv-driven diseases induced by temperature-sensitive
folding deficits. This mechanism was seen in our work and
has been seen by others, including in persistent hyperin-
sulinemic hypoglycemia of infancy caused by mutant
pancreatic ATP-sensitive potassium SUR1/Kir6.2 channels
[45] and in long QT type 2 syndrome caused by Kv11.1
channel mutations [46].
In our second scenario, loss of function of all WT/mu-
tant heterocomplexes might occur with low KChIP2 levels,
such as decline of expression during aging or due to
SCA19/22 mutations. Although some studies have reported
on KChIP expression and function in the adult rodent
cerebellum [47–50], no aging-related expression studies in
human cerebellum have been reported thus far. Since no
clear differences were observed in the expression levels of
KChIPs in the human temporal cortex of middle-aged or
older individuals (data extracted from GEO database IDs:
79781991, 79784404, and 79795297), it remains to be
established how far such haploinsufficiency may also
contribute to disease.
For the third scenario, we have shown that, in addition to
the haploinsufficiency, all mutant Kv4.3 subunits also ex-
hibit dominant effects on WT Kv4.3 channel function, even
in the presence of KChIP2, which may contribute to dis-
ease onset and progression. This is especially true for
T352P, which strongly suppressed current amplitude when
this mutant subunit co-assembled with WT Kv4.3. The
threonine to proline substitution at position 352 in the pore
region is seemingly extremely damaging, and we suspect
that this mutation leads to a full collapse of the channel
pore and thereby complete inactive channels complexes
despite its cellular localization. Consequently, WT/T352P
bFig. 3 KChIP2 drives the formation of stable WT/mutant Kv4.3
heterocomplexes at plasma membrane. a Confocal images of
permeabilized and fixed HeLa cells expressing KChIP2 together with
HA–WT/EGFP–WT homocomplexes or HA–WT/EGFP–mutant
heterocomplexes (green) stained with anti-HA (blue) and anti-
KChIP2 (red) antibodies. In the presence of KChIP2, all WT/mutant
heterocomplexes were detected at the plasma membrane (merged in
violet). Scale bar 20 lm. b Flow cytometry was used to quantify the
percentage of cells expressing the extracellular HA-tagged Kv4.3 WT
(black bars) or mutant subunits (gray bars) in the presence of KChIP2
at the plasma membrane of non-permeabilized HeLa cells. Similar
levels of HA–Kv4.3 WT were detected at the plasma membrane for
WT/WT homocomplexes vs. WT/mutant heterocomplexes (WT/WT:
79.5 % vs. WT/T352P: 77.8 %, WT/M373I: 71.8 %, WT/S390N:
75.1 % and WT/DF227: 75 %). Similarly, the levels of HA-tagged
Kv4.3 mutants at plasma membrane for mutant/WT heterocomplexes
were similar to WT/WT homocomplexes (WT/WT: 87.5 % vs. WT/
T352P: 71.6 %, WT/M373I: 71 %, WT/S390N: 80.3 % and WT/
DF227: 69.6 %). c Time course cycloheximide (CHX) experiments
were performed in HeLa cells expressing the EGFP-WT/WT
homocomplexes or EFGP–WT/mutant heterocomplexes in the pres-
ence (black lines) or absence (red lines) of KChIP2, and the
remaining protein was analyzed by Western blot and quantified.
Notably, in the presence of KChIP2, all WT/mutant heterocomplexes
were significantly more stable (black lines) than the heterocomplexes
without KChIP2 (red lines). Data in b and c represent the average of
three independent experiments and the error bars represent the
mean ± SEM, t test in b showed no significant differences and
*p\ 0.00001 vs. KChIP2 presence in c. In c the graphs represent the
Western blot protein densitometries normalized by actin, showing the
percentage of the remaining Kv4.3 protein
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Fig. 4 T352P-mutant Kv4.3 suppresses Kv4.3 WT activity by a
dominant mechanism. a–f Representative current traces, recorded in
oocytes at*18 C with a two-electrode voltage clamp 1–3 days after
RNA injection, are shown for a WT, bM373I, c S390N, d DF227, e a
1:1 mixture of WT and DF227 and f T352P. Currents were evoked by
pulsing from a holding potential of -100 mV to voltages ranging
from -80 to ?70 mV in 10 mV increments. For clarity, every other
trace has been omitted. g Representative current traces evoked at
?60 mV are shown for oocytes injected with WT, T352P or indicated
ratios of WT:T352P RNA have been overlaid. h WT or T352P were
expressed separately or at a 1:1 ratio keeping the amount of WT RNA
constant. Normalized peak current amplitudes measured at ?60 mV
were WT alone, 1.00 ± 0.06 (n = 24); WT:T352P at a 1:1 ratio,
0.48 ± 0.09 (n = 30); and T352P alone, 0.02 ± 0.01 (n = 7). The
1:1 ratio differed significantly from WT alone, evaluated using a one-
way ANOVA followed by Student’s t test (§p\ 0.00001). i Current
density plot. Normalized peak current amplitude as a function of
voltage is shown for wild type (black squares), DF227 (red circles),
wild type:DF227 expressed at a 1:1 molar ratio (green triangles) or
wild type:T352P expressed at a 1:1 molar ratio (blue inverted
triangles). RNA encoding KChIP2 was co-injected at an equimolar
ratio with the total amount of Kv4.3 RNA. Peak current amplitudes
were measured as a function of voltage and normalized to that for
wild-type Kv4.3 expressed in parallel in the same batch of oocytes.
Data from different batches of oocytes were then averaged (n = 12).
Data are provided as mean ± SEM. Statistical significance was
assessed using data obtained at ?50 mV: *significantly different from
wild type (*p\ 0.05) by ANOVA followed by Tukey’s post hoc test;
NS not significantly different from wild type
Table 1 Functional properties of WT and SCA19/22-mutant Kv4.3 channels
Activation Time to peak (ms) I150ms/Ipeak Inactivation
V,act (mV) Slope (mV) V,inact (mV) Slope (mV) srec (ms)
Kv4.3 WT -20 ± 1 (29)a 17 ± 0.3 (29) 9.9 ± 0.4 (29) 0.47 ± 0.02 (29) -58 ± 1 (24) 5 ± 0.1 (24) 244 ± 15 (18)
DF227 7 ± 1 (18)§,b 18 ± 1 (18) 12.6 ± 0.7 (18)# 0.25 ± 0.02 (18)§ -50 ± 1 (12)§ 6 ± 0.3 (12)§ 108 ± 5 (9)§
WT:DF227 (1:1) -11 ± 1 (14)§ 18 ± 1 (14) 10.0 ± 0.3 (13) 0.42 ± 0.01 (13) -57 ± 1 (15) 5 ± 0.1 (15) 206 ± 20 (15)
T352Pc ND ND ND ND ND ND ND
WT:T352P (1:1) -20 ± 1 (24) 18 ± 1 (24) 7.4 ± 0.4 (23)§ 0.39 ± 0.02 (23) -60 ± 1 (14) 5 ± 0.3 (14) 245 ± 14 (7)
M373I -20 ± 1 (12) 15 ± 1 (12) 12.0 ± 0.3 (12) 0.49 ± 0.01 (12) -53 ± 2 (13) 5 ± 0.2 (13) 279 ± 17 (4)
WT:M373I (1:1) -18 ± 1 (5) 14 ± 2 (5)* 12.8 ± 0.1 (5) 0.39 ± 0.03 (5) -54 ± 1 (6) 5 ± 0.3 (6) ND
S390N -19 ± 1 (10) 19 ± 1 (10)* 6.8 ± 0.5 (10)# 0.34 ± 0.01 (10)# -63 ± 2 (10) 4 ± 0.1 (10)* 194 ± 14 (4)
WT:S390N (1:1) -17 ± 2 (2) 19 ± 1 (2) 7.5 ± 0.9 (2) 0.24 ± 0.03 (2) -63 ± 1 (4) 6 ± 1 (4) ND
In all cases, KChIP2 RNA was co-expressed in 1:1 molar ratio with WT Kv4.3 RNA
ND not done
a Values are provided as mean ± SEM (n = number of measurements)
b Statistical significance compared with WT was evaluated by one-way ANOVA followed by Student’s t test: * p\ 0.05;  p\ 0.005;
# p\ 0.0005; § p\ 0.00001
c T352P did not produce functional channels when expressed alone
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heterocomplex channels exhibited significant changes in
their time to reach peak amplitude and their I150ms/Ipeak
ratio compared to WT alone, indicating that a limited
number of mutant subunits were able to be incorporated
into active, cell surface channels. These results indicate
that incorporation of one T352P subunit in an otherwise
WT channel was not sufficient to abolish channel activity
in oocytes, although the suppression of the current ampli-
tude is dose dependent. Furthermore, dominant alterations
in gating of the heterocomplex Kv4.3 channel were ob-
served, since the activation and inactivation shifts of all
WT/mutant heterocomplexes, except for WT/T352P hete-
rocomplexes showed values between the WT and the
mutant homocomplexes. Dominant suppression of channel
activity and altered gating were also described for many of
the mutant Kv3.3 heterocomplex channels underlying
SCA13 [27–29].
All SCA19/22 mutations may modify the outward
A-type potassium currents in neurons, leading to changes
in the interspike interval of action potentials in Purkinje
cells and other cerebellar neurons, such as basket cells or
stellate cells that might cause neuronal degeneration
similar to the mechanism observed in SCA13 [30]. Since
there are no in vivo disease models for SCA19/22, we
assume that loss of intrinsic pacemaking in Purkinje cells
could underlie motor dysfunction and ataxia, as has been
seen in episodic ataxia type 2 mice [28]. The exact role of
Kv4.3 in the interspike interval in Purkinje cells remains
unknown [51], but some of the gating deficits, including
the shift of V,inact in the hyperpolarized direction of the
WT/S390N heterocomplexes and the reduced activity of
the WT/T352P heterocomplexes (as was seen for a Kv4.2
dominant negative mutant [52, 53]), may both lead to
shorter interspike intervals and bursts of action potentials.
Fig. 5 SCA19/22 mutations alter the functional properties of Kv4.3
homocomplexes and heterocomplexes. a Conductance values were
calculated from peak current amplitudes assuming a linear open
channel current–voltage relationship and normalized to the maximum
value obtained in the experiment. Normalized conductance values
were plotted as a function of test voltage for WT (black squares),
DF227 (open circles), a 1:1 mixture of WT and DF227 (red circles), a
1:1 mixture of WT and T352P (green triangles), M373I (blue inverted
triangles) and S390N (diamond symbols) and data were fitted with a
single Boltzmann function to obtain values for V,act and the slope
factor (see Table 1). b Representative current traces evoked by
pulsing from -100 to ?60 mV have been scaled and overlaid for WT
(black), DF227 (magenta), a 1:1 mixture of WT and DF227 (red), a
1:1 mixture of WT and T352P (green), M373I, (blue) and S390N
(cyan). c The box plot shows the time to reach peak current amplitude
at ?60 mV. d The box plot shows the I150ms/Ipeak ratio, calculated by
dividing the current amplitude remaining at the end of a 150 ms pulse
by the peak current amplitude. e Steady-state inactivation was
evaluated using a two-pulse protocol. Peak amplitudes during the test
pulse were normalized to the peak amplitude in the absence of a
prepulse (I/Imax) and plotted versus prepulse voltage. Data were fitted
with a single Boltzmann function (solid curves) to obtain values for
V,inact and the slope factor (see Table 1). f To measure the rate of
recovery from inactivation, currents were evoked by pulsing from -
80 to ?60 mV for 400 ms (pulse 1). The voltage was then returned to
-80 mV for variable durations ranging from 500 to 1100 ms, in
40 ms steps, prior to a second pulse to ?60 mV for 400 ms (pulse 2).
The fractional recovery was calculated as the peak amplitude during
pulse 2 divided by the peak amplitude during pulse 1 (I/Imax) and
plotted versus the interpulse duration. Each data set was fitted with a
single exponential function to obtain the time constant for recovery
(srec) (Table 1). Data are shown as mean ± SEM. In b and c,
statistical significance compared to WT alone was evaluated by one-
way ANOVA followed by Student’s t test: p\ 0.005; #p\ 0.0005;
§p\ 0.00001. Mean values ± SEM of the time to peak and the
I150ms/Ipeak ratio are provided in Table 1. Results obtained with 1:1
mixtures of WT:M373I and WT:S390N are provided in Table 1
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Our data clearly show the complexity of establishing a
common pathological mechanism underlying SCA19/22, a
complexity consistent with the clinical heterogeneity of
this disease. Based on our results, we can only establish a
relationship between the loss of function of the T352P
mutant channel and a more severe phenotype and an earlier
age of disease onset in patients, and between channel
gating deficits caused by M373I, S390N and DF227 and
milder ataxic symptoms. However, future work should
prove whether SCA19/22-induced alterations in synaptic
activity are associated with reduced neuronal survival and
will reveal the role that these alterations play in neuro-
protection [54].
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